GlassScriptPhysician profile
Ahmed Tahmid Haque
NPI 1487184628
$3,661.19
in general payments reported to CMS, 2019-2025
21 companies · $652 in 2025
The $652 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.93 · 2021: $1,833 · 2022: $494 · 2023: $421 · 2024: $251 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,169.18 | 2021-2025 | Varithena Administration Pack, General - Pain Management |
| Medtronic, INC. | $1,014.18 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Nevro Corp. | $413.72 | 2021-2024 | Senza |
| Forte Bio-Pharma LLC | $148.79 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Biotronik Nro, INC. | $144.13 | 2023-2025 | Biotronik, Prospera |
| Abbott Laboratories | $105.25 | 2023-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $88.03 | 2024-2025 | Evoke |
| Si-Bone, INC. | $79.64 | 2019-2024 | |
| Pfizer INC. | $62.62 | 2023-2024 | |
| Stryker Corporation | $60.11 | 2021 | |
| Globus Medical, INC. | $59.67 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $51.35 | 2025 | |
| Scilex Pharmaceuticals INC. | $44.45 | 2022-2025 | Ztlido |
| Abbvie INC. | $42.38 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $35.67 | 2025 | Xtampza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.24 | 2025 | Relistor |
| Averitas Pharma INC. | $31.77 | 2024 | Qutenza |
| Azurity Pharmaceuticals, INC. | $31.21 | 2025 | Horizant |
| Valinor Pharma, LLC | $17.69 | 2025 | Movantik |
| Lundbeck LLC | $16.80 | 2023 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.